OssDsign (OSSD) ABGSC Investor Days summary
Event summary combining transcript, slides, and related documents.
ABGSC Investor Days summary
9 Jul, 2026Company overview and business model
Focuses on property with three main business areas: investment management, principal investments, and corporate finance.
Manages SEK 160 billion in assets, with operations in 12 countries and assets in 16.
Nearly 60% of revenues are recurring, providing business stability.
Sustainability and long-term client relationships are core to operations.
Established a strong pan-European platform over 35 years.
Strategic priorities and operational changes
Priorities include growing AUM, reducing risk, and simplifying operations.
Principal investments will be integrated into core operations for clearer reporting and risk reduction.
Balance sheet will be used for co-investments and seeding funds to drive recurring revenues.
Corporate finance has been revitalized and streamlined for efficiency.
Focus remains on scalable pan-European products for institutional investors.
Market environment and financial performance
Transactional volumes have declined sharply but are now slowly recovering.
Investment management has grown AUM by over 15% annually since 2015, even during downturns.
AUM growth has shifted from fund inflows to asset management mandates.
Maintained a solid cash position by exiting markets ahead of downturns and adapting operations.
Net cash position is strong, with SEK 1.6 billion in cash and SEK 1.3 billion in debt.
Latest events from OssDsign
- Q1 revenue declined 17.1% in SEK and 3.6% in USD, but H2 momentum is expected.OSSD
Q1 202610 May 2026 - Sales up 45% to SEK 180.2M, 96.3% margin, U.S. expansion, aiming for SEK 400M by 2028.OSSD
Q4 20253 Feb 2026 - Q2 net sales up 143%, gross margin at 93.2%, and major U.S. contracts secured.OSSD
Q2 202423 Jan 2026 - Q3 2024 delivered 114% sales growth, 96.9% gross margin, and narrowed losses.OSSD
Q3 202415 Jan 2026 - Record growth and high margins drive rapid U.S. expansion in orthobiologics.OSSD
ABGSC Investor Days12 Jan 2026 - Sales up 107% and gross margin above 95%, with strong U.S. growth and improved cash flow.OSSD
Q4 20248 Jan 2026 - SEK 158M raised to fund U.S. expansion, targeting SEK 400M+ sales and profitability by 2028.OSSD
Strategy Update27 Nov 2025 - Q2 sales up 73% at constant FX, gross margin 96.8%, and SEK 160M raised for U.S. growth.OSSD
Q2 202523 Nov 2025 - Sales up 65%, clinical data strong, and U.S. market access at 10% with major growth ahead.OSSD
ABGSC Investor Days21 Nov 2025